News on the latest health tech of Asian markets
Luye Partners AZ To Further Promote Its Cardiovascular Product Xuezhikang
Luye Pharmaceutical Group announced an agreement with AstraZeneca China to authorize the latter to exclusively promote Xuezhikang capsule products in mainland China. This is...
Exploring the model of AI & Pathology, Histo won Pre-A round financing
The Shanghai-based Histo Pathology Diagnostic Center (also known as “Histo”) recently completed the A+ round of financing. This round of financing was jointly led...
UCDOM completed the Pre-A round of financing invested by Fosun Pharma, focusing on drug...
UCDOM, a company focuses on informatized and intelligentized product development, announced that it has completed the Pre-A round of financing invested by Shanghai Fosun...
Hotgen Won A New Round Investment From GTJA Group
Hotgen Biotech Co.,Ltd (hereinafter referred to as Hotgen) was awarded a new round of investment by GTJA Investment group.
Established in June 2005, Hotgen focuses...
Medbanks completed 400 million D round of financing, focusing on cancer & special drugs
In the fourth quarter of 2018, Medbanks , a Beijing-based integrated medical management technology company focusing on cancer and special medicines, successfully completed the...